Integrating disulfidptosis-related long noncoding RNAs in colorectal cancer prognosis: A path to precision medicine

doi:10.5306/wjco.v15.i5.664

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (303)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

250

Sum=259

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=34

May 24, 2024 (publication date) through Jun 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Clin Oncol. May 24, 2024; 15(5): 664-666
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.664

Integrating disulfidptosis-related long noncoding RNAs in colorectal cancer prognosis: A path to precision medicine

Shi-Yan Zhang

Shi-Yan Zhang, Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, Fuding 355200, Fujian Province, China

Author contributions: Zhang SY wrote and edited the manuscript.

Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Shi-Yan Zhang, MD, Director, Doctor, Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, No. 120 South Road of Old City, Fuding 355200, Fujian Province, China. myebox@139.com

Received: February 2, 2024
Revised: March 5, 2024
Accepted: April 9, 2024
Published online: May 24, 2024

Core Tip

Core Tip: This commentary emphasizes the novel role of disulfidptosis-related long noncoding RNAs (lncRNAs) in colorectal cancer prognosis. Focusing on the intersection of genetic research and clinical practice, it highlights how the study of lncRNAs can facilitate the development of targeted therapies and prognostic models. The critical evaluation of recent research underscores the potential of lncRNAs as biomarkers and therapeutic targets, marking a significant step towards personalized medicine in colorectal cancer treatment.